-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$29.0064.87% Upside
Zealand Pharma A/S Frequently Asked Questions
-
What analysts cover Zealand Pharma A/S?
Zealand Pharma A/S has been rated by research analysts at Goldman Sachs, Needham in the past 90 days.